Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07008898 · ClinicalTrials.gov registry record · NA
Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy
A NA study of Pelvic Organ Prolapse and Stress Incontinence Female, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 2
- Study locations
NCT07008898: Recruiting NA study of Pelvic Organ Prolapse and Stress Incontinence Female, sponsored by University of Alabama at Birmingham.
NCT07008898 is a NA study of Pelvic Organ Prolapse and Stress Incontinence Female that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 110 participants, below the 142-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (23% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07008898, a NA study of Pelvic Organ Prolapse and Stress Incontinence Female, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study looks at the best time to place a midurethral sling (MUS), which is a small piece of mesh used to treat stress urinary incontinence (SUI) (leaking urine when you cough, laugh, or exercise). The sling is placed during a type of surgery called robotic sacrocolpopexy (RSC). This surgery helps fix pelvic organ prolapse, when organs like the bladder or uterus drop from their normal place. Doctors can place the sling either before or after they lift and support the top of the vagina during surgery, but they aren't sure which timing works better. In this study, investigators are comparing what is the best time to place the sling, how the patient feels after surgery and if a patient's symptoms got better or worse.
Primary Outcome
The primary outcome will be change between baseline and 3 months stress urinary incontinence symptoms as measured by the UDI-6. Scores for the UDI-6 range from 0 to 100 has an MCID of 5.8, with higher scores indicating worse symptoms.
Conditions Studied
Interventions
- PROCEDURE Midurethral sling placed before robotic sacrocolpopexy
- PROCEDURE Midurethral sling placed after robotic sacrocolpopexy
Study Locations (2)
Alabama
- University of Alabama at Birmingham - Birmingham
New York
- Albany Medical Center - Albany
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2025-07-08 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT07008898 shows while recruiting
NCT07008898 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 142-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (23% lower).
The record links to 2 conditions, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 2 interventions - of which Midurethral sling placed before robotic sacrocolpopexy is the first listed.
NCT07008898 reports a single indexed study location in Alabama, New York.
Frequently Asked Questions
What is clinical trial NCT07008898 about?
NCT07008898 is a clinical study titled "Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy". This study looks at the best time to place a midurethral sling (MUS), which is a small piece of mesh used to treat stress urinary incontinence (SUI) (leaking urine when you cough, laugh, or exercise). The sling is placed during a type of surgery called robotic sacrocolpopexy (RSC). This surgery help...
What is the current status of trial NCT07008898?
This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2025-07-08. Estimated completion is 2027-06.
What conditions does trial NCT07008898 study?
This clinical trial studies the following conditions: Pelvic Organ Prolapse, Stress Incontinence Female.
What interventions are being tested in trial NCT07008898?
The interventions under investigation include: Midurethral sling placed before robotic sacrocolpopexy (PROCEDURE), Midurethral sling placed after robotic sacrocolpopexy (PROCEDURE).
Who is sponsoring clinical trial NCT07008898?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07008898 being conducted?
This trial has 2 study locations across Alabama, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Organ Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07008898's enrollment target sits among peer trials
110 17th of 40 higher than 22 of 40 other Pelvic Organ Prolapse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pelvic Organ Prolapse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
RECRUITING · NA
-
The AccelERate Trial
RECRUITING · NA
-
Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI